| Literature DB >> 31000917 |
Uday Pratap Singh1, Rahul Jena1, Kumar Madhavan1, Naveen Kumar1, Sanjay Kumar Sureka1, Aneesh Srivastava1.
Abstract
INTRODUCTION: We present the short-term voiding patterns and functional and urodynamic outcomes of W-shaped ileal orthotopic neobladder (ONB) following radical cystectomy (RC).Entities:
Year: 2019 PMID: 31000917 PMCID: PMC6458799 DOI: 10.4103/iju.IJU_356_18
Source DB: PubMed Journal: Indian J Urol ISSN: 0970-1591
Figure 1W-shaped ileal orthotopic neobladder using 40 cm of terminal ileum. Ureters are implanted into serosa lined extramural tunnels
Clinicopathological parameters of patients with bladder cancer
| Parameters | Value |
|---|---|
| Number of patients | 41 |
| Age (years), mean±SD | 58.3±12.4 |
| Body mass index (kg/m2) | 27.7±5.3 |
| Follow-up (months) | |
| Mean (range) | 19.4 (6-37) months |
| HPE and pathological T-stage [ | |
| CIS | 1 (2.5) |
| pT1 | 8 (19.5) |
| pT2 | 24 (58.5) |
| pT3 | 4 (9.7) |
| Urachal adenocarcinoma | 3 (7.3) |
| Squamous cell carcinoma | 1 (2.5) |
| Pathological N stage [ | |
| pN0 | 30 (73.2) |
| pN+ | 11 (26.8) |
| Comorbidities [ | |
| Diabetes | 7 (17.1) |
| Hypertension | 10 (24.4) |
| COPD | 2 (4.7) |
| Chemotherapy [ | |
| Neoadjuvant | 4 (9.8) |
| Adjuvant | 14 (34.1) |
HPE=Histopathological examination, COPD=Chronic obstructive pulmonary disease, CIS=Carcinoma in situ, SD=Standard deviation
Voiding pattern and urodynamic pattern of patients after orthotopic neobladder
| Parameters | Values | ||
|---|---|---|---|
| 3 months | 6 months | ||
| Voiding pattern ( | |||
| Incontinence status ( | |||
| No incontinence | 23 (60.5) | 28 (73.7) | |
| Night time incontinence only | 12 (31.6) | 9 (23.7) | |
| Both day and night incontinence | 3 (7.9) | 1 (2.6) | |
| Severity of incontinence | |||
| Mild (few drops) | 11 (73.3) | 7 (70) | |
| Moderate (underwear wetting) | 3 (20.0) | 2 | |
| Severe (cloth wetting) | 1 (0.7) | 1 | |
| Frequency of incontinence episodes | |||
| Day time (mean value) | 2.8 | 2.6 | |
| Night time (mean value) | 4.3 | 4.0 | |
| Urodynamic pattern ( | |||
| Maximum reservoir capacity (ml) | 436.3±103.5 | ||
| Maximum filling pressure (cm H2O) | 24.6±8.5 | ||
| Pouch compliance (ml/cm H2O) | 50.6±17.8 | ||
| Pabd (abdominal pressure) at Qmax (cm H2O) | 105.5±35.7 | ||
| Ppouch (pouch pressure) at Qmax (cm HO) | 16.8±7.2 | ||
| Maximum flow rate (mL/s) | 14.7±5.3 | ||
| Average flow rate (mL/s) | 7.2±3.4 | ||
| Postvoid residual volume (mL) | 123.7±42.5 | ||
| Uroflowmetry pattern ( | |||
| Bell type (%) | 17 (43.8) | ||
| Fractionated type (%) | 18 (47.4) | ||
| Plateau type (%) | 3 (7.8) | ||
Figure 2Pouch urethrography showing spherical shaped pouch, no reflux with good emptying
Postoperative complications
| Complications | Presentation | |
|---|---|---|
| Asymptomatic lower urinary tract infections | 8 | Detected on routine culture |
| Deterioration in renal function and acidosis | 3 | |
| Upper tract changes | 2 | Bilateral in 1 case |
| High drain output | 6 | |
| Wound infection | 2 | Discharge from wound |
| Pouch leak | 2 | |
| Acute pyelonephritis | 2 | Fever with sepsis |
| Bladder neck stenosis | 1 | |
| Ureteric anastomotic stricture | 1 | Evaluation for left hydroureteronephrosis |
| Incisional hernia | 1 |
Figure 3Endoscopic view of the left ureteric orifice during guide wire placement for balloon dilatation followed by rigid ureteroscopy
Health-related quality of life assessment of patients after orthotopic neobladder
| Domains | Value (mean±SD) |
|---|---|
| EORTC QLQ-C30 functional scale (0-100) | |
| Physical functioning domain | 82.4±25.2 |
| Role functioning domain | 75.7±29.1 |
| Emotional functioning domain | 85.3±13.5 |
| Cognitive functioning domain | 91.4±6.8 |
| Social functioning domain | 79.7±14.6 |
| Global quality of life scale | 62.7±23.2 |
| EORTC QLQ-C30 functional scale: A high scale score represents an high/healthy level of functioning (0-100) except for the global quality of life scale a high scale score represents a low level of functioning | |
| EORTC QLQ-C30 symptoms scale and single items | |
| Fatigue | 21.5±11.8 |
| Nausea and vomiting | 4.5±2.3 |
| Pain | 15.4±7.3 |
| Insomnia | 17.3±11.2 |
| Dyspnea | 16.5±5.6 |
| Appetite loss | 19.2±11.2 |
| Constipation | 17.3±5.3 |
| Diarrhea | 14.9±11.2 |
| Financial difficulties | 29.5±16.3 |
| EORTC QLQ-C30 symptoms scale and single items: A high scale score represents an high level of symptomatology/problems (0-100) | |
| EORTC QLQ-BLM30 | |
| Urinary symptoms | 34.5±16.7 |
| Future perspective | 28.5±17.2 |
| Abdominal bloating and flatulence | 18.7±12.1 |
| Body image | 24.8±14.3 |
| Sexual functioning | 23.5±15.6 |
| EORTC QLQ-BLM30: A high scale score represents an high level of symptomatology/problems (0-100) | |
| IONB-PRO | |
| Relation life domain | 56.4±25.4 |
| Emotional life domain | 43.6±23.2 |
| Fatigue domain | 48.5±18.5 |
| IONB-PRO: A high scale score represents an high/healthy level of functioning (0-100) | |
IONB-PRO=Ileal Orthotopic Neobladder-Patient-Reported Outcome, EORTC QLQ-BLM30=European Organization for Research and Treatment of Cancer Bladder Cancer-Specific Instruments, SD=Standard deviation